Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

29.90 -0.59 (-1.94%)
Streaming Delayed Price Updated: 1:34 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2
...
24 25 26 27 28 29 30 31 Next >
News headline image
Lilly Shares Up On Versanis Deal Amid Weight-Loss Drug Gold Rush
A bid to acquire Versanis boosts Eli Lilly & Co. by 2.80% in the past week, as the competition to develop the most effective weight-loss drug intensifies. 
Via MarketBeat
News headline image
3 Small-Cap Stocks That Could Be Big-Time Winners ↗
These stocks come with significant risks. But they could generate huge returns over time. 
Via The Motley Fool
News headline image
The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly? ↗
An overweight world is hungry for new treatments. For now, two companies own the market. 
Via Investor's Business Daily
News headline image
3 Top Biotech Stocks Defying the Bear Market ↗
Each has the potential to dramatically outperform the market. 
Via The Motley Fool
News headline image
2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher ↗
Are analysts right to be so bullish about these stocks? 
Via The Motley Fool
News headline image
Expert Ratings for Viking Therapeutics ↗
 
Via Benzinga
News headline image
Could Viking Therapeutics Stock Help You Become a Millionaire? ↗
Should you buy into the hype? 
Via The Motley Fool
News headline image
Why Viking Therapeutics Stock Is Heating Up Today ↗
Positive analyst coverage is fueling another uptick in the biotech's stock today. 
Via The Motley Fool
News headline image
The 3 Best Momentum Stocks to Buy in July ↗
For those who identify the right shares at the right time, the rewards of momentum stocks far outstrip those of their competitors. 
Via InvestorPlace
News headline image
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023 ↗
If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead. 
Via InvestorPlace
News headline image
Better Buy: Nano-X Imaging vs. Viking Therapeutics ↗
Which healthcare stock is the better option for growth investors? 
Via The Motley Fool
News headline image
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says ↗
Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) shares lost more than 25% of their value due to investor pressure it faced after Eli Lilly And Co (NYSE: LLY) announced data from retatrutide that was... 
Via Benzinga
News headline image
Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Viking Therapeutics Inc. (NASDAQ: VKTX) is a Stock Spotlight on 5/23
Via Investor Brand Network
News headline image
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. 
Via Benzinga
News headline image
Why Viking Therapeutics Is Plunging Today ↗
The biotech's shares are being negatively impacted today by mid-stage data for a competing weight loss drug. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Viking Therapeutics Stock Is Crashing Today ↗
Investors seem concerned about the company's competitive positioning in weight loss. 
Via The Motley Fool
News headline image
2 Low-Priced Stocks That Could Make You Richer ↗
These two low-priced healthcare stocks could skyrocket within the next 12 months. 
Via The Motley Fool
News headline image
3 Biotech Stocks to Buy as Companies Ink Major Deals ↗
Pharmaceutical and biotech companies will soon face generic competition, creating big opportunity for these top biotech stocks to buy. 
Via InvestorPlace
News headline image
7 Healthcare Stocks to Make You the Millionaire Next Door ↗
For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy. 
Via InvestorPlace
News headline image
After Blasting Off 881% in 1 Year, Is Viking Therapeutics Still a Good Buy? ↗
The risks are high, and the rewards are uncertain for new buyers. 
Via The Motley Fool
News headline image
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money. ↗
One of these stocks has already doubled this year. 
Via The Motley Fool
News headline image
If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position ↗
All three healthcare stocks have soared this year, but their share prices may not be sustainable. 
Via The Motley Fool
News headline image
Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics? ↗
Which of these red-hot biotech stocks is the better buy right now? 
Via The Motley Fool
News headline image
Buying Shares of These 2 Biotech Stocks Could Be a Brilliant Move in 5 Years ↗
If you can tolerate the risk and have some patience, both stocks could blossom. 
Via The Motley Fool
News headline image
This Red-Hot Growth Stock Has Soared 885% in Just 12 Months ↗
Is it too late to buy shares of Viking Therapeutics? 
Via The Motley Fool
News headline image
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street ↗
Recent moves to the upside could be the beginning of a much larger bull run. 
Via The Motley Fool
News headline image
3 Biotech Stocks Sitting on Huge-Upside Catalysts ↗
The biotech boom is hot. According to Grand View, it could be worth $2.44 trillion. It's why we have an eye on these top biotech stocks. 
Via InvestorPlace
News headline image
The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes ↗
Pfizer stock surged on its diabetes news this week, but one analyst says there's a key piece missing from the story. 
Via Investor's Business Daily
< Previous 1 2
...
24 25 26 27 28 29 30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.